Recent advances in CT and nuclear medicine will take center stageat Elscint's RSNA booth. In CT, the Israeli firm will introduceSeleCT/SP, a new entry-level spiral CT platform targeted at developingcountries. SeleCT/SP is a compact 1.8-second scanner
Recent advances in CT and nuclear medicine will take center stageat Elscint's RSNA booth. In CT, the Israeli firm will introduceSeleCT/SP, a new entry-level spiral CT platform targeted at developingcountries.
SeleCT/SP is a compact 1.8-second scanner that features solid-statedetectors, like Elscint's premium CT-Twin scanner. It can cover60 cm in a single 60-second spiral acquisition with resolutionof 12 lp/cm and a field-of-view of 485 mm.
MasterWorks is a new set of CT image processing techniques tobe shown for the first time. MasterCut enables clinicians to delineatea curve of interest along vessels or airways. MasterMatch is amultimodality image registration package, while MasterFilm allowsimages to be previewed and edited before printing.
In nuclear medicine, Elscint will highlight its digital Varicamadjustable-angle dual-head gamma camera, introduced earlier thisyear (SCAN 6/7/95). Elscint is awaiting 510(k) clearance for thecamera, according to Richard Brown, marketing manager.
The company's TransACT attenuation correction protocol, whichworks on both Varicam and the CardiaL 90° dual-head camera,recently received the Food and Drug Administration's nod. In nuclearmedicine image processing, Elscint will show a new version 4.0release of its XPert workstation software that supports new applications,including gated SPECT and image registration.
Elscint has beefed up its prowess in PACS with a sales and marketingagreement with Agfa. Elscint will integrate Agfa's Impax systemand its DryStar printer with its own products and will bring Agfasales reps into its sites where connectivity solutions are needed.Elscint recently formed a connectivity department to help integrateits products with those of other vendors using the DICOM 3.0 standard.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.